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Modulation of cell:cell junctions is a key event in cutaneous wound repair. In this study we report that activation of the epidermal
growth factor (EGF) receptor disrupts cell:cell adhesion, but with diﬀerent kinetics and fates for the desmosomal cadherin
desmoglein and for E-cadherin. Downregulation of desmoglein preceded that of E-cadherin in vivo and in an EGF-stimulated
in vitro wound reepithelialization model. Dual immunoﬂuorescence staining revealed that neither E-cadherin nor desmoglein-
2 internalized with the EGF receptor, or with one another. In response to EGF, desmoglein-2 entered a recycling compartment
based on predominant colocalization with the recycling marker Rab11. In contrast, E-cadherin downregulation was accompanied
by cleavage of the extracellular domain. A broad-spectrum matrix metalloproteinase inhibitor protected E-cadherin but not the
desmosomal cadherin, desmoglein-2, from EGF-stimulated disruption. These ﬁndings demonstrate that although activation of
the EGF receptor regulates adherens junction and desmosomal components, this stimulus downregulates associated cadherins
through diﬀerent mechanisms.
1.Introduction
During cutaneous wound repair, epidermal cells at the
wound margin undergo phenotypic and functional changes
including increased proliferation, migration, and a partial
epithelial-to-mesenchymal transition (EMT) characterized
bydisruption ofcell:celljunctions,changesin cell:substrate
adhesion,andretractionandreorganizationofthecytoskele-
ton [1–3]. Kalluri and Weinberg proposed three sub-clas-
siﬁcations of EMT with type 2 EMT associated with wound
healing, tissue regeneration, and organ ﬁbrosis [4]. An
essential aspect of type 2 EMT is that once repair is achieved
epithelial phenotype and tissue integrity is restored. A
hallmarkof successfulwound repair is the reestablishment of
cell:cell junctions and barrier function, thereby illustrating
dynamicmodulationofadherensjunctionsanddesmosomes
during wound reepithelialization. In mouse epidermis, a
decrease in E-cadherin is evident 3 days after wounding in
full-thickness incisional or excisional wound models with
subsequent protein restoration upon wound closure [5].
Blocking E-cadherin function with antibody caused uneven
wound margins and disruption of the reor- ganizing actin
cytoskeleton in mouse epidermis [6], demonstrating the
importance of E-cadherin in wound repair. Similarly, the
dissolution of hemidesmosomes, which connect the cell to
the extracellular matrix, and desmosomes responsible for
cell:cell contacts occurs during wound healing [7, 8]b u t
little is known about modulation of desmosomal cadherins
during wound repair.
A number of mechanisms have been reported to regulate
the assembly and disassembly of adherens junctions and de-
smosomes in cells including phosphorylation of junctional2 Dermatology Research and Practice
components [9–12], cadherin cleavage [13–18], and endo-
cytic mechanisms [19–26]. Certain signaling molecules such
as PKC-α are expressed and activated at the wound margin
and contribute to the loss of desmosomal adhesion [27]. The
epidermal growth factor (EGF) receptor is another impor-
tant regulator of wound repair. EGF receptor expression
is elevated at the leading edge of healing wounds in mice
[28, 29] and humans [29], and EGF stimulates wound repair
in vivo [30–32]. Furthermore, keratinocyte migration in
vitro and epithelial outgrowth in vivo are decreased in EGF
receptor null skin [30] indicating that EGF receptor activity
isimportantforoptimalwoundrepair.ActivationoftheEGF
receptor also induces expression of transcriptional regulators
of EMT such as Snai2 and regulates junctional assembly
and disassembly in keratinocytes [12, 33–38]. It remains
unclear how activation of these signaling pathways aﬀect the
junctional stability of both desmosomes and adherens junc-
tions to facilitate reepithelialization.
In this study, we investigated the eﬀects of EGF receptor
activation on the fate of E-cadherin and desmoglein-2, a des-
mosomal cadherin that is elevated in healing wounds [39].
We ﬁnd that downregulation of desmoglein precedes that of
E-cadherin in vivo a n di nE G F - s t i m u l a t e din vitro wound
reepithelialization models. Importantly, we ﬁnd evidence for
diﬀerential regulation of adherens junctions and desmoso-
mal complex proteins as a consequence of EGF receptor
activation. Furthermore, EGF-stimulated downregulation of
E-cadherin and demsoglein-2 displays distinct temporal and
spatial patterns and involves diﬀerent mechanisms. These
ﬁndings indicate that the same stimulus leads to diﬀerent
outcomes for classical versus desmosomal cadherins in kera-
tinocytes.
2.MaterialsandMethods
2.1. Cell Line and Reagents. Squamous cell carcinoma (SCC)
12F cells were originally derived from a tumor of the facial
epidermis and generously provided by Dr. William A.
Toscano, Jr. (University of Minnesota, Minneapolis, MN).
SCC 12F cells are nontumorigenic and express EGF receptor
levels similar to those detected at the margins of heal-
ing wounds. SCC 12F cells were maintained on 10cm2
plates in Dulbecco’s modiﬁed Eagle’s medium:Ham’s F-
12 nutrient mixture (DMEM:F-12) containing 5% (v/v)
iron-supplemented deﬁned calf serum (HyClone Laborato-
ries, Inc., Logan UT), 2mM L-glutamine, and antibiotics
(penicillin, 100U/mL, streptomycin, 50μg/mL). For all ex-
periments involving growth factor addition, SCC 12F cells
wereplacedintoDMEM:F-12containing0.1%(w/v)bovine
serum albumin (BSA) for 24 hours prior to growth fac-
tor addition. Murine epidermal growth factor (EGF) was
obtained from Biomedical Technologies Inc. (Stoughton,
MA). GM6001X was purchased from Chemicon (Temec-
ula, CA). AG1478 was purchased from Enzo Life Scien-
ces (Plymouth Meeting, PA). DMEM:F-12, BSA, Penicil-
lin/Streptomycin,andL-glutaminewerepurchasedfromSig-
ma Chemical Co. (St. Louis, MO).
2.2. Immunohistochemistry. 129 Young adult male mice were
shaved and depilated using Nair (Church and Dwight,
Princeton, NJ). Two days later, mice were anesthetized, skin
of the upper dorsum was tented, and paired 3mm-diameter
excisional wounds were introduced using a sterile disposable
biopsy punch. Mice were sacriﬁced by CO2 inhalation 48
hours later. Skin containing the wound sites and underlying
muscle was removed, spread on thin cardboard, ﬁxed in
10% neutral buﬀered formalin, embedded in paraﬃn, and
sectioned at 4μm. For immunohistochemistry, sections were
deparaﬃnized and rehydrated. Endogenous peroxidase was
blocked by a 10-minute incubation in aqueous 3% H2O2,
and microwave antigen retrieval was performed in 10mM
citrate buﬀer, pH 6.0. Nonspeciﬁc antibody binding was
blocked using Biocare Blocking Reagent (Concord, CA). For
E-cadherin immunohistochemistry, slides were incubated
for 1 hour in a 1:50 dilution of a rabbit polyclonal antibody
(sc7870, Santa Cruz, Santa Cruz, CA), then for 30 minutes
with Envision plus labeled polymer-anti-rabbit-HRP (Dako,
Carpinteria, CA). Desmoglein was detected using a mouse
monoclonal antibody (CBL174, Millipore, Billerica, MA)
diluted 1:100 for a 1-hour incubation, followed by a
15-minute incubation with biotinylated rabbit-anti-mouse
F(ab)’ (Accurate Chemical, Westbury, NY) diluted 1:250
and a 30-minute incubation with SA-HRP (BioGenex, San
Ramon, CA). All incubations were performed at room tem-
perature, and immunoreactivity was detected using diami-
nobenzidine as chromagen. Slides were counterstained with
hematoxylin, dehydrated, and cover-slipped.
2.3. In Vitro Wound Healing Assay. For evaluation of in vitro
reepithelialization, conﬂuent cell monolayers were deprived
of serum and growth factors for 24 hours, and a cell-
free area was introduced by scraping the monolayer with a
standard dimension blue pipette tip (USA Scientiﬁc, Ocala,
FL) followed by extensive washing to remove cellular debris.
In vitro reepithelialization was monitored by repopulation
of the cleared area (wound width typically between 200–
300mm) with cells over time either in the presence or
absence of the EGF receptor inhibitor AG1478.
2.4. Immunoblotting of Protein and Conditioned Medium.
Cells were lysed either with SDS collection buﬀer (10mM
Tris pH 7.5, 1% SDS, 5mM EDTA, 2mM EGTA, 1mM
PMSF, 1μg/mL leupeptin, 1μg/mL pepstatin A) to collect
total protein, or by subcellular fractionation. For subcellular
fractionation, cells were lysed with 0.05% saponin collection
buﬀer (10mM Tris pH 7.5, 140mM NaCl, 0.05% saponin,
5mM EDTA, 2mM EGTA, 1mM PMSF, 1μg/mL leupeptin,
1μg/mL pepstatin A) and then centrifuged at 14,000rpm;
the resulting supernatant represented the saponin, or cyto-
plasmic, fraction. The pellet was then fully resuspended in
1% triton collection buﬀer (10mM Tris pH 7.5, 140mM
NaCl, 1% Triton X-100, 5mM EDTA, 2mM EGTA, 1mM
PMSF, 1μg/mL leupeptin, 1μg/mL pepstatin A) and then
centrifuged, and the resulting supernatant was labeled the
triton soluble, or membrane-associated fraction. Finally,
the remaining pellet was fully resuspended in 1% SDSDermatology Research and Practice 3
collection buﬀer, and this was labeled the triton insoluble,
or cytoskeletal-associated (junction bound) fraction. Pro-
tein concentrations were determined by bicinchoninic acid
(BCA)colorimetricassay(Pierce,Rockford,IL).Equalquan-
tities of protein were fractionated on 8% (w/v) SDS poly-
acrylamide gels and transferred onto polyvinylidene ﬂuoride
(PVDF) membranes. Conditioned medium was collected
from6wellplates(1mLtotalvolume)andthenconcentrated
using a centrifugal ﬁlter device (Millipore, Bedford, MA)
with a 30,000 molecular weight cutoﬀ. The retentate was
collected and resolved on an 8% (w/v) SDS polyacrylamide
gel, then transferred onto a polyvinylidene ﬂuoride (PVDF)
membrane. Immunoblotting was performed as described
below. Membranes were blocked in 5% (w/v) nonfat dry
milk in Tris-buﬀered saline with 0.05% Tween-20 (TBST)
for 1 hour at room temperature before the addition of pri-
mary antibody. Primary antibodies [E-cadherin (clone
NCH-38, Dakocytomation, Carpinteria, CA), E-cadherin
(Santa Cruz Biotechnology, Santa Cruz, CA), desmoglein-
2 (clone 6D8, Invitrogen, Carlsbad, CA), and alpha-catenin
(Chemicon, Temecula, CA)] for western blots were used at
1:1000 dilution and incubated at room temperature for 1
hour. The membranes were washed with TBST three times,
and secondary antibody horseradish peroxidase labeled goat
anti-mouse from Promega (Madison, WI), at a dilution of
1:10,000 in 5% (w/v) milk was added for 1 hour at room
temperature. The membranes were washed with TBST three
times and developed using the SuperSignal chemilumines-
cent detection system (Pierce, Rockford, IL). Visualization
and densitometry of the blots were obtained with the Kodak
Image Station 440 System (New England Nuclear, Boston,
MA).
2.5. Immunoﬂuorescence. SCC 12F cells were seeded in a
Lab Tek II chamber slide system (Nalge Nunc Internation-
al, Naperville, IL). Cells were transferred to serum-free
medium and then treated with 20nM EGF for various
times, or pretreated with the broad spectrum MMP inhibitor
GM6001X for 30 minutes prior to addition of EGF. To
probe for junctional proteins, cells were ﬁxed with cold
dry methanol for 2 minutes, or alternatively with freshly
prepared paraformaldehyde (3.7%) for 10 minutes. Para-
formaldehyde slides were triton-permeabilized for an addi-
tional 5 minutes. The slides were then blocked in 3% (w/v)
BSA in complete PBS (phosphate-buﬀered saline containing
0.8mM magnesium chloride and 0.18mM calcium chlo-
ride) at 37◦C in a humidiﬁed chamber. For detection of
lysosomal colocalization, Lysotracker (Invitrogen, Carlsbad,
CA) was added at a 1:250 dilution to live cells 2 hours
before ﬁxation. Primary antibodies were used at a 1:100
dilution and included: beta-catenin (Chemicon, Temecula,
CA), plakoglobin, caveolin-1, pancytokeratin (Santa Cruz,
Santa Cruz, CA), E-cadherin (HECD-1 clone), desmoglein-
2 (clone 6D8, Invitrogen, Carlsbad CA), EEA1 (Aﬃnity
Bioreagents, Golden, CO), epidermal growth factor receptor
(Upstate, Chicago, Il.), rab11 (rabbit polyclonal Ab), and
rab7 (chicken polyclonal Ab), both kindly provided by Dr.
Angela Wandinger-Ness, University of New Mexico. Primary
antibody was incubated for 1 hour at 37◦C in a humidi-
ﬁed chamber. Slides were washed three times in complete
PBS; then a ﬂuorophore-conjugated secondary antibody (In-
vitrogen, Carlsbad, CA) was added at a 1:300 dilution and
was allowed to incubate for 1 hour at 37◦C in a humidiﬁed
chamber. Actin staining was obtained by incubating with
TRITC-labeledPhalloidin(0.5μg/mL,Sigma,St.Louis,MO)
for 30 minutes at room temperature. Slides were washed
three times in complete PBS then mounted with a cov-
erslip using Vectashield mounting medium (Vector Labs,
Burlingame, CA). Images were obtained with an inverted
microscope (Olympus IX70, Melville NY) and MagnaFire
software 2.1 (Optronics, Goleta, CA) or with a Zeiss confocal
Microscope (Zeiss, Thornwood, NY).
2.6. PCR. RNA was isolated using 0.5mL Trizol (Invitrogen
Life Technologies, Carlsbad, CA), following the manufactur-
er’s instructions. cDNA was synthesized from total RNA. All
PCR reagents were purchased from Promega (Madison, WI).
Primers were ordered from Sigma-Genosys (The Wood-
lands, TX) and included the following: E-cadherin (For-
ward, GGGTGACTACAAAATCAATC, Reverse, GGGGGCA-
GTAAGGGCTCTTT), desmoglein-2 (Forward, CACTATG-
CCACCAACCACTG, Reverse, TTAGGCATGGCCAGAGTA-
GG), and 18s rRNA (Forward, AAACGGCTACCACATCC-
AAG, Reverse, CCTCCAATGGATCCTCGTTA). E-cadherin
ampliﬁcation was performed with an initial denaturation
step at 94◦Cf o r4m i n u t e s ,f o l l o w e db y3 8c y c l e sw i t ha
denaturing step at 94◦ for 30 seconds, an annealing step of
55◦C for 30 seconds and an extension step of 72◦Cf o r3 0
seconds, and a ﬁnal extension step of 72◦Cf o r4m i n u t e s .
Desmoglein-2 ampliﬁcation was performed as above, with
the annealing step of 64◦C for 30 seconds, for a total of
30 cycles. 18s rRNA ampliﬁcation was performed with an
initial denaturation step at 94◦C for 4 minutes, followed by
20 cycles with a denaturing step at 94◦ f o r3 0s e c o n d s ,a n
annealing step of 55◦C for 30 seconds and an extension step
of 72◦C for 30 seconds, and a ﬁnal extension step of 72◦Cf o r
4 minutes. GoTaq Flexi products (Promega, Madison, WI)
were used according to the manufacturer’s protocols. The
resulting PCR products were loaded onto a 3% agarose gel
(EMD Chemicals, San Diego, CA). SYBR Safe DNA gel stain
(Invitrogen, Carlsbad, CA) was added for staining purposes,
andthegelwasimagedonaKodakImageStation440System
(New England Nuclear, Boston, MA).
2.7. Statistical Analysis. Results from diﬀerent treatment
groups in immunoblotting experiments were compared by
Welsh’s t-test, and the value for statistical signiﬁcance was
considered at P<0.05.
3. Results
3.1. Wound Margins In Vivo Show a Decrease in E-Cadherin
and Desmoglein at the Migrating Epithelial Tip. Both E-
cadherinanddesmogleinwerestudiedinaninvivoincisional
wound model. After 48 hours after incision, the epithelium
stained for both E-cadherin (Figure 1,l e f tp a n e l )a n d4 Dermatology Research and Practice
Figure 1: Cadherin staining 48h postincisional wounding in vivo. Left Panel: E-cadherin immunoreactivity at wound margin 48h after
introduction of an incisional wound. Bar = 150μm. Inset: Higher magniﬁcation of the advancing edge of epithelium. Note that E-
cadherin immunoreactivity is present in all but a few cells at the very tip of the migrating epithelium. Bar = 50μm. Right Panel:
Desmoglein immunoreactivity at wound margin 48h after introduction of an incisional wound. Bar = 150μm. Inset: Higher magniﬁcation
of the advancing edge of epithelium. Note that desmoglein immunoreactivity is largely absent from the tip of the migrating epithelium.
Bar = 50μm.
desmoglein (Figure 1, right panel), throughout a majority
of the intact epithelium. However, at the migrating wound
edge, both E-cadherin and desmoglein displayed a marked
decrease in staining (Figure 1, insets of both panels, E-
cadherinwaspresentinallbutafewcellsatthemigratingtip,
demonstrating the persistence of this cadherin throughout
the epithelium even 48 hours post injury. Desmoglein, how-
ever, is largely absent from the migrating front. Clearly, a
downregulation of both cadherins occurs as a normal re-
sponse to wounding in vivo, although the degree of down-
regulation of each cadherin diﬀers 48 hours post injury.
3.2.EGFReceptorActivationIsRequiredforJunctionalDisrup-
tion at Wound Margins. EGF receptor activation stimulates
wound repair in vivo [30, 40] and disrupts junctional com-
plexes in vitro [41, 42]. We conducted in vitro wound
closure assays using SCC 12F cells, a well-diﬀerentiated
squamous cell carcinoma line [43] with EGF receptor levels
comparable to those at wound margins [36]t oi n v e s t i g a t e
the status of junctional complexes at an in vitro wound
border as a function of EGF receptor activity (Figure 2).
Modest wound closure occurs in serum-free conditions,
and exogenous EGF greatly stimulates the response. Both
basal and EGF-stimulated migration into the wound area
was inhibited by the EGF receptor tyrosine kinase inhibitor
AG1478 (Figure 2(a)). The loss of basal migration is likely
due to inhibition of the autocrine EGF receptor activation
in this system [44]. Junctional disruption was detected
at wound margins as evidenced by the loss of catenin
border staining under basal (no exogenous EGF) conditions
(Figure 2(b), arrows). In contrast, EGF receptor inhibition
led to retention of catenin staining at cell borders of cells
at the wound edge, suggesting that junctional integrity
was retained (Figure 2(b), arrowheads). Similar results were
obtainedforE-cadherinanddesmoglein-2(datanotshown).
3.3. Downregulation of Junctional Proteins by EGF Receptor.
EGF receptor activity has been reported to modulate certain
junctional proteins, leading to downregulation and protein
degradation [9, 45–47]. The catenins are well studied, but
less is known regarding the fate of cadherins in response to
EGF receptor activation. Using sequential detergent extrac-
tion, we compared protein levels of membrane-associated
(triton soluble) versus junction bound (triton insoluble)
cadherins. Extended exposure to EGF led to loss of both the
desmosomal cadherin desmoglein-2 and adherens junction
protein E-cadherin from the cell membrane and junction-
associated protein pools (Figure 3). Since transcriptional
repression of E-cadherin is one reported mechanism of
down-regulation [48, 49], we examined mRNA levels for E-
cadherinanddesmoglein-2inresponsetoEGF(Figure 3(b)).
In a time course that spanned 48 hours, no change in
either E-cadherin or desmoglein-2 transcripts occurred. In
agreement with the in vitro wound model, a decrease in
the protein levels of both beta-catenin and plakoglobin was
detected in the membrane- and junction-associated protein
fractions (data not shown). Interestingly, not all junctional
components were aﬀected, as the levels of the adherens junc-
tional linker protein alpha-catenin were retained following
EGF treatment (Figure 3(a)).
There was a notable diﬀerence in the time dependence
for loss of cadherin protein in the membrane-associated
versus junction-associated protein pools in response to EGF.
The triton soluble, membrane-associated fraction, showed a
decrease in desmoglein-2 protein as early as 6 hours, whereas
E-cadherin was not signiﬁcantly decreased until 24 hours
after EGF exposure (Figure 3(a), asterisks P<0.05). Simi-
larly, in the triton insoluble fraction, a signiﬁcant decrease
in desmoglein-2 protein was evident at 2 hours post-EGF
treatment whereas little change in E-cadherin was evident
untillatertimepoints(Figure 3(b),asterisksP<0.05).These
ﬁndings indicate that E-cadherin and desmoglein-2 are not
coordinately regulated during reepithelialization.
3.4. EGF-Dependent Downregulation of Desmoglein-2 Pre-
cedes E-Cadherin. The cellular localization of E-cadherinDermatology Research and Practice 5
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Figure 2: Junctions at the wound margin are retained upon EGF receptor inhibition. Cells were grown to conﬂuence, placed in serum-
free medium overnight, and then a wound was introduced with a pipette tip. Cells were washed 3X with PBS, then placed in serum-free
medium +/−20nM EGF and +/−5μM of the selective EGF receptor inhibitor AG1478 as indicated for 24h. (a) The area of wound closure
was measured using ImagePro software. (b) After wounding, cells were ﬁxed and immunostained for either gamma-catenin (plakoglobin) or
beta-catenin. Note the loss of border staining is limited to the wound edge (see arrows). Upon EGF receptor inhibition, junctional proteins
are apparent at the wound edge (see arrowheads).
and desmoglein-2 following EGF receptor activation con-
ﬁrmed the diﬀerences observed in the cell fractionation
studies.Internalizationofdesmoglein-2wasevidentwithin6
hours of EGF treatment as detected by punctate intracellular
staining (Figure 4(a), white arrows). In contrast, E-cadherin
staining was retained at the cell borders after EGF treatment
(Figure 4(a), arrowheads). Loss of both cadherins from cell
borders was evident after 24 hours of EGF treatment. Similar
internalization kinetics were observed for the desmosomal
cateninplakoglobinandtheadherensjunctionalcomponent,
beta-catenin (data not shown).
Immunostainingofthecorrespondingcytoskeletonpart-
ners shows disruption of the desmosomal-associated cytok-
eratin network at 6 hours, consistent with the time frame
of desmosomal cadherin internalization (Figure 4(b)). In
contrast,the adherens junction-associated actin cytoskeleton
remains intact at this timepoint and is maintained at 8
hours following EGF treatment, consistent with E-cadherin
localization. Disruption of the actin skeleton was evident
24 hours posttreatment (data not shown). These ﬁndings
indicate that functional disruption of desmosomes precedes
that of adherens junctions.
3.5. Internalization Fate of Desmoglein-2. Several studies
document E-cadherin internalization in response to growth
factors [19, 50–52]; however, EGF-stimulated traﬃcking of
desmosomal cadherins has not been well described. EGF
receptor activation stimulates multiple traﬃcking pathways
including clathrin-dependent and –independent traﬃcking
itineraries [19, 53, 54]. EGF stimulates clathrin-dependent
EGF receptor internalization [55, 56], although the receptor
can undergo clathrin-independent internalization under
certain situations such as oxidative stress [57]. Neither E-
cadherin nor desmoglein-2 colocalized with the EGF recep-
tor following EGF receptor activation, and EGF receptor
internalization preceded that of desmoglein-2 by several
hours (Figure 5, white arrows). These ﬁndings indicate
that although desmoglein-2 internalizes in response to
EGF receptor activation, the two proteins do not follow
the same itinerary. Dual immunoﬂuorescence staining for6 Dermatology Research and Practice
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Figure 3: EGF regulation of cadherin proteins in membrane and cytoskeleton-associated pools. Cells were grown to subconﬂuence, placed
inserum-freemediumovernight,andthentreatedwithEGFfortheindicatedtimes.DG2:desmoglein-2,EC:E-cadherin,AC:alpha-catenin.
(a) Sequential detergent extraction separates the triton soluble (membrane-associated) fraction, from the triton insoluble, (cytoskeletal, or
intact junctional) fraction. Blots are representative of a minimum of three separate experiments. Bar graphs represent the densitometric
quantiﬁcation of each lane normalized to no treatment control, with asterisks indicating statistical signiﬁcance. (P<0.05) (b) Cells were
treated with or without EGF for the indicated times, and mRNA level was measured by PCR. Bar graphs represent the densitometric
quantiﬁcation of bands normalized to no treatment control.
desmoglein-2 and E-cadherin reveals that desmoglein-2 col-
ocalizes with E-cadherin at the cell surface, but not in the
cytosol post EGF treatment (Figure 6) further indicating
distinct fates for the two cadherins.
Toestablishwhetherdesmoglein-2internalizationoccurs
through the classical endosomal pathway or through alter-
nate internalization pathways, we used markers of the clas-
sical endosomal pathway (EEA-1, Rabs) as well as markers
for caveolae-dependent internalization (caveolin-1). A small
fraction of desmoglein-2 was present in EEA-1-positive
early endosomes. However, there was little evidence of des-
moglein-2 colocalizing with rab7, a late endocytic vesicleDermatology Research and Practice 7
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Figure 4: Diﬀerent kinetics for disruption of desmosomes and
adherens junctions by EGF. (a) SCC 12F cells were treated with
EGF for the indicated times, ﬁxed, and then probed with E-
cadherin or desmoglein-2 antibodies. Note the relocalization of
the desmosomal cadherin desmoglein-2 from the cell borders
followingtreatmentwithEGFfor4–6h(whitearrows).Thispattern
diﬀers from that observed for the adherens junctional cadherin, E-
cadherin, where strong border staining is evident at 6 hours post
EGF treatment (white arrowheads). (b) Cells were treated with
EGF, ﬁxed, and then stained with phalloidin to stain the actin
cytoskeleton, or with a pan-cytokeratin antibody, to label keratin
ﬁlaments. Disorganization of the keratin network is seen at 6 hours
(whitearrow),whiletheactincytoskeletonremainsintactat8hours
posttreatment (white arrowheads).
marker, nor with lysotracker, a marker of lysosomes, for up
to 12 hours post EGF treatment (summarized in Table 1).
Similarly, desmoglein-2 did not colocalize with caveolin-
1, a marker for the caveosomal-dependent traﬃcking. The
majority of desmoglein-2 colocalized with the recycling
marker Rab11 (Figure 7(a)). Colocalization was analyzed
usingMander’soverlapcoeﬃcientsk1andk2[58],wherethe
k1 coeﬃcient described the amount of cadherin colocalized
Desmoglein-2 EGFR Merge
0h
EGF
30m
EGF
(a)
EGFR Merge
0h
EGF
30m
EGF
E-cadherin
(b)
Figure 5: Cadherins do not cointernalize with the EGF receptor.
SCC 12F cells were treated with 20nM EGF for 30 minutes,
ﬁxed, and probed for EGF receptor (green) or junctional cadherin
(red). White arrows indicate the internalized EGF receptor in the
cytoplasm while both junctional cadherins, desmoglein-2 (upper
panel), and E-cadherin (lower panel) remain at the cell surface 30
minutes post EGF treatment.
Table 1: Localization of cadherins with endocytic traﬃcking mark-
ers. Colocalization experiments were conducted using immunoﬂu-
orescence techniques and confocal microscopy as described in
“Methods”. EGF treatment ranged from 2–12 hours, and experi-
ments were repeated a minimum of 3 times. (−) indicates no colo-
calization at any timepoint; (±) indicates colocalization at the plas-
mamembranebutnotincytoplasm;(+)indicatesvesicularcolocal-
ization in at least one timepoint; (+++) indicates colocalization in
vesicles at several timepoints.
Endosomal compartment Desmoglein-2
colocalization
E-cadherin
colocalization
EEA1 (Early endosome) +N . T .
Rab11 (Recycling endosome) +++ −
Rab7 (Late endosome) −−
Lysotracker (Lysosome) + −
Caveolin-1 (Caveosome) +( ±)
with Rab11 as compared to total cadherin levels. Over an 8-
hour time course, desmoglein-2 colocalization with Rab11
increased (Figure 7(b)) and at 6- and 8-hour time points,8 Dermatology Research and Practice
0h EGF
6h EGF
8h EGF
Merge E-cadherin Desmoglein-2
Figure 6: Desmoglein-2 does not internalize with E-cadherin. SCC 12F cells were treated with EGF for the indicated times, ﬁxed, then
probed with E-cadherin or desmoglein-2 antibodies. The desmosomal cadherin desmoglein-2 is relocalized from the cell borders at 6–8hrs
after EGF treatment. Note punctate cytoplasmic staining (white arrows). This pattern diﬀers from that observed for the adherens junctional
cadherin, E-cadherin, where strong border staining is evident at 6 hours post EGF treatment.
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Figure 7: Desmoglein-2 colocalizes with Rab11, a recycling marker. (a) SCC 12F cells were treated for the indicated times with 20nM EGF,
thenﬁxedwith3.7%formaldehydeandpermeabilizedwith0.1%TritonX-100.Cellswerestainedwithantibodiesagainstbothdesmoglein-2
and rab11. Secondary antibodies tagged with either FITC or Rhodamine were used. Colocalization is detected by the appearance of yellow
staining where the red and green overlap, particularly in EGF-treated cells (white arrows). (b) Mandler’s overlap coeﬃcient, k1, measures
the ratio of cadherin colocalized with Rab11 to total cadherin present.Dermatology Research and Practice 9
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Figure 8: EGF receptor activation leads to accumulation of an E-cadherin extracellular fragment in conditioned medium. Subconﬂuent
cells were serum-starved (without BSA in the medium) for 24 hours. Cells were treated with 20nM EGF for the indicated times, then the
conditioned medium was collected, concentrated, and resolved on an 8% SDS gel. Samples of conditioned media were normalized to the
corresponding protein lysate, transferred onto PVDF, and probed with an antibody against the extracellular epitope of E-cadherin, which
recognizes both full length (120kD) and cleaved E-cadherin (80kD).
both proteins were present in small punctate vesicles on the
plasma membrane and in the cytosol. This colocalization
was statistically signiﬁcant at the 6- and 8-hour time points
(Figure 6(b), P<0.05) whereas E-cadherin showed no
increase in k1 over the same timepoints. Together, these
ﬁndings indicate that EGF promotes desmoglein-2 inter-
nalization through a predominantly recycling rather than
a lysosomal degradation pathway and represents a novel
internalization fate for desmoglein-2.
3.6. EGF Receptor Activation Stimulates E-Cadherin Cleavage.
In contrast to desmoglein-2, EGF treatment led to a gradual
decrease in the intensity of E-cadherin staining at cell-
cell borders without an emergence of punctate intracellular
staining indicative of internalization after 8-hour treatment
(see Figure 6). However, at these same timepoints, E-cad-
herin cleavage as a consequence of EGF receptor activa-tion
was detected by immunoblotting for the 80kD E-cad- herin
ectodomain. A signiﬁcant increase in an 80kD E-cadherin
fragment in the conditioned medium was evident 18 hours
and 24 hours after EGF treatment (Figure 8). There was
no evidence for desmoglein-2 cleavage products under the
same conditions (data not shown). Accumulation of the
EGF-dependent 80kD E-cadherin fragment was prevented
by pretreatment with a broad-spectrum matrix metallopro-
teinase (MMP) inhibitor GM6001X. Although there is some
internalized E-cadherin after 18 hours of EGF treatment,
cells pretreated with the MMP inhibitor retain signiﬁcant
junctional E-cadherin staining at the plasma membrane
(Figure 9). Conversely, this protection was not extended to
the desmosomal cadherin desmoglein-2, as internalization
was independent of the MMP inhibitor. Taken together,
these studies indicate distinct fates for the desmosomal
cadherin desmoglein-2 as compared to the classical cadherin
E-cadherin upon EGF stimulation.
4. Discussion
The EGF receptor is a signiﬁcant regulator of cutaneous
woundrepairbasedonexperimentalstudies,geneticmodels,
and evidence for accelerated healing in patients [28–30].
I nt h i ss t u d yw ed e m o n s t r a t et e m p o r a ld i ﬀerences in EGF-
dependent down-regulation of E-cadherin and desmoglein-
2. Our studies demonstrate a decrease of desmosomal func-
tion precedes that of adherens junctions in vivo and for the
EGF-stimulated responses in vitro. This ﬁnding is consistent
with previous reports that assembly of adherens junctions
is necessary for the formation of desmosomes [59]. The
potential signiﬁcance of desmosomal disruption preceding
that of adherens junctions may be related to the requirement
ofkeratinocytestoformamigratoryepithelialsheetfromthe
stratiﬁed epidermis [1]. It has been noted that conversion to
a single cell layer requires down-regulation of desmosomal
adhesion [60]. Importantly, we provide evidence that the
EGF-stimulated disruption of the two types of junctions is
related to diﬀerent underlying mechanisms for the down-
regulation of cadherin function.
EGF receptor activation led to accumulation of an 80kD
E-cadherin fragment in conditioned medium, and a broad-
spectrum MMP inhibitor protected adherens junctions from
EGF-dependent disruption. Extracellular cleavage of E-
cadherin is a well-studied mechanism, and several proteases,
including MMP-3, -7 [18], -9 [16], MT1-MMP, ADAM10
[61] and ADAM15 [62], as well as plasmin [17], kallikrein
7[ 63], and γ-secretase [64, 65] cleave E-cadherin. EGF is
a known inducer of MMPs and other proteases, and there is
evidence for EGF-stimulating MMP-dependent E-cadherin
cleavage [16, 35, 66–71]. Although the internalization
of E-cadherin has been reported in several models and
occurs through clathrin-dependent [24, 25, 50, 72–74],
clathrin-independent [75, 76], and caveolae-dependent [54]10 Dermatology Research and Practice
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Figure 9:EﬀectofMMPinhibitiononmembranelocalizationofE-cadherinordesmoglein-2afterEGFtreatment.Cellswereserum-starved
for 24 hours then treated with 50μM of the broad spectrum MMP inhibitor GM6001X for 30 minutes before addition of 20nM EGF for the
indicatedtimes.CellswerethenﬁxedandprobedwitheitheranE-cadherinantibodythatrecognizestheintracellularepitopeordesmoglein-
2 antibody. White arrows indicate the internalized desmoglein-2 even in the presence of inhibitor, while the white arrowheads indicate the
retention of E-cadherin at the cell-cell borders.
pathways, the endocytic fate of E-cadherin appears to vary
according to the stimulus presented and cell context [54, 77,
78]. Src activation promotes clathrin-dependent endocytosis
of E-cadherin [25], yet clathrin-independent mechanisms
were reported following EGF stimulation of the MCF-7
and A431 cell lines by micropinocytosis [19]a n dc a v e o l a r -
dependent internalization [54], respectively. In contrast to
studies demonstrating cointernalization of E-cadherin with
the tyrosine kinase receptors c-Met and FGFR1 [50, 51],
we did not ﬁnd evidence for concurrent traﬃcking of EGF
receptor with either E-cadherin or desmoglein-2.
Similar to E-cadherin, extracellular cleavage of desmoso-
mal cadherins has been reported. The appearance of a 60kD
fragment of desmoglein-3 occurs in vitro in keratinocytes
treated with patient sera with pemphigus vulgaris [15]. In a
highly invasive squamous cell line that forms sparse cell:cell
junctions, a 100kD desmoglein-2 fragment was detected in
low-calcium (.09mM) conditions, and production of this
fragment was reversed by inhibition of the EGF receptor and
the inhibition of several members of the sheddase family
of ADAMS (a disintegrin and metalloprotease), including
ADAM17 [79]. ADAM 17 has been shown by others to be
increased in response to EGF [80] and to cleave desmoglein-
2[ 81]. Our studies suggest that EGF receptor-stimulated
desmoglein-2 cleavage is not the predominant mechanism in
this experimental system.
There is additional evidence that desmosomal cadherins
can be internalized in response to various stimuli. In HaCat
cells, desmoglein-1 underwent internalization in response to
sera collected from pemphigus vulgaris and pemphigus foli-
aceus patients as early as 6 hours with a concurrent decrease
in the amount of desmoglein-1 found in the membrane-
associated fraction postexposure [21]. Internalization of
desmoglein-3 in response to pemphigus autoantibody was
found to undergo clathrin-independent internalization [22],
early endosomal localization [23], and subsequent lysosomal
degradation [20]. Both EGF receptor-dependent and -inde-
pendent mechanisms have been proposed [82–84].
The potential signiﬁcance of reversible mechanisms for
downregulation of cadherins may be related to characteris-
tics of the partial EMT present at wound margins [1]. There
has been increased appreciation that partial EMT includesDermatology Research and Practice 11
processes of dynamic junctional modulation and retention
of cell cohesion rather than complete cell dissociation and
migration of individual cells. As examples, both in culture
and in vivo, maintenance of cell:cell contact of migrating
neural crest cells is necessary for movement persistence and
oriented migration [85]. In the Drosophila tracheal system,
dynamic modulation of junctions through endocytosis and
recycling maintains tissue stability during migratory pro-
cesses [86], and during gastrulation, posttranslational regu-
latory mechanisms such as E-cadherin protein degradation
andturno v erappeart obeimportant[85].Onecharacteristic
of cohesive migrating epithelial is that cells at the edge of
these tissues appear more mesenchymal [87]a sw eo b s e r v e
at the edge of wound margins in vitro and in vivo (Figures 1
and 2).
Collectively, the data indicates that there are numerous
traﬃcking itineraries and mechanisms of cadherin down-
regulation that may be dependent upon the initial signal-
ing event. Our studies demonstrate EGF-stimulated down-
regulation of E-cadherin and desmoglein-2 through distinct
mechanisms; EGF-dependent cleavage of E-cadherin and
entry of desmoglein-2 into a recycling traﬃcking itinerary.
These distinct mechanisms may help account for the
observeddiﬀerencesinthemodulationofadherensjunctions
and desmosomes during wound repair in vivo.
5. Conclusions
Modulation of adherens junctions and desmosomes is an
essentialcomponentofreepithelialization,yetwedonothave
afullunderstandingofthemechanismsthatgovernassembly
and disassembly of these structures and, in particular, the
fate of the respective cadherins. In this study we demonstrate
that EGF downregulates E-cadherin and desmoglein-2, but
with diﬀerent kinetics and through distinct mechanisms.
Activation of the EGF receptor leads to E-cadherin cleavage
through an MMP-dependent mechanism. In contrast, a des-
mosomal cadherin, desmoglein-2, is internalized and local-
izes predominantly within a recycling compartment rather
than traﬃcking to lysosomes, thereby representing a novel
fate in response to growth factor activation. This study illus-
trates that the same stimulus can lead to divergent out-
comes for disruption of adherens junctions and desmosomal
complexes, and diﬀerent fates for the corresponding cad-
herins. Understanding how various stimuli direct cadherin
traﬃcking and downregulation will likely prove important
to understanding junctional modulation in physiologic and
pathophysiologic conditions.
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